ID: ALA5206472

Max Phase: Preclinical

Molecular Formula: C31H48N2O8

Molecular Weight: 576.73

Associated Items:

Representations

Canonical SMILES:  COC(=O)C[C@@H]1C[C@@]2(CO2)[C@H](O)[C@@H](/C=C/C(C)=C/C[C@@H]2O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)NC(=O)C(C)C)C[C@@H]2C)O1

Standard InChI:  InChI=1S/C31H48N2O8/c1-18(2)30(37)32-21(5)10-13-27(34)33-24-14-20(4)25(40-22(24)6)11-8-19(3)9-12-26-29(36)31(17-39-31)16-23(41-26)15-28(35)38-7/h8-10,12-13,18,20-26,29,36H,11,14-17H2,1-7H3,(H,32,37)(H,33,34)/b12-9+,13-10-,19-8+/t20-,21-,22+,23+,24+,25-,26+,29+,31+/m0/s1

Standard InChI Key:  AEKGVHIUIYKTFT-AYMDAWMLSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 576.73Molecular Weight (Monoisotopic): 576.3411AlogP: 2.74#Rotatable Bonds: 11
Polar Surface Area: 135.72Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.92CX Basic pKa: CX LogP: 2.23CX LogD: 2.23
Aromatic Rings: 0Heavy Atoms: 41QED Weighted: 0.15Np Likeness Score: 2.07

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source